Boston Magazine reporter Dana Guth writes that MIT researchers are programming harmless strains of E. coli bacteria to destroy tumor cells. Guth explains that the programmed bacteria could be ingested or injected and “could offer a new way to stave off liver cancer.”
MIT researchers have developed a programmable vaccine that could be used to respond to disease outbreaks, reports Ben Gruber for Reuters. The vaccine harnesses “messenger RNA, a genetic material that can be programmed to fight any viral, bacterial or parasitic disease by provoking an amplified immune response.”
An image created by researchers at the Koch Institute that shows red nanoparticles carrying MicroRNAs to an aggressive breast tumor is featured in the National Cancer Institute Cancer Close Up project. Washington Post reporter Laurie McGinley explains that the photographs are intended to spark public interest and encourage young people to consider a career in microbiology.
CNN’s Jareen Imam writes that MIT researchers have developed a new topical solution that can make wrinkles invisible and could potentially deliver medications to the skin. "We hope this can be used for many different things," explains Prof. Daniel Anderson. "For example, if you need it for a large area of skin you might put it on like sunscreen."
CBS This Morning highlights the “second skin” material developed by MIT researchers that can help tighten wrinkles and protect the skin. CBS News medical contributor Dr. David Agus says that the material is “really an amazing work in chemical engineering,” highlighting how the material could be used to deliver medication to the skin.
A new material developed by MIT researchers could assist with everything from tightening wrinkles to delivering medication to the skin, reports Enjoli Francis for ABC News. Prof. Robert Langer explains that the material is invisible and “conforms to the skin. You can use it to deliver a drug, if you want, and it's mechanically quite strong."
FOX 25 reports on the new polymer developed by MIT researchers that can smooth wrinkles and could one day potentially deliver medications to the skin. The material is a “‘silicone-based polymer’ that acts as a kind of ‘second skin,’ and could be used to provide protection from the sun.”
Washington Post reporter Rachel Feltman writes about the new “second skin” material developed by MIT researchers. The researchers found that the new material “could actually find its best use in patients with severe skin problems like eczema or psoriasis, which can both cause extremely dry and itchy skin.”
Prof. Robert Langer speaks with Scientific American reporter Gary Stix about the material he and his colleagues developed that can tighten skin and deliver medications. Langer explains that the material is an “ointment that you can apply very easily but then the way we've set up the chemistry, it actually hardens and becomes almost like an invisible Band-Aid.”
A new material developed by MIT researchers can help smooth wrinkles, protect the skin from sun damage and could one day even administer medications, reports Gina Kolata for The New York Times. “We made literally hundreds of polymers,” explains Prof. Robert Langer. “We were looking for safety, spreadability, adherence, and the right kind of mechanical and optical properties.”
MIT researchers have developed a transparent, silicon-based polymer that can protect skin from sun damage and smooth out wrinkles, writes Amina Khan for The Los Angeles Times. Prof. Robert Langer explains that users of the material will “hardly know that it’s on. It sort of conforms to the skin.”
BBC News reporter Michelle Roberts writes that MIT researchers have developed a new material that can hide wrinkles and could eventually be used to deliver medicines and sun protection. The researchers found that skin “coated with the polymer was more elastic than skin without the film. And, to the naked eye, it appeared smoother, firmer and less wrinkly.”
Researchers from MIT and Mass General Hospital have been named one of the winners of Popular Science’s 2016 Invention Awards for their work developing an ingestible electronic device that measures vital signs, reports Dialynn Dwyer for Boston.com.
A team of MIT researchers has been selected as the winner of the Koch Institute research-grant pitch competition for their work on developing a diagnostic platform for early-stage leukemia, reports Amanda Hoover for Boston.com. Hoover explains that the diagnostic method would “single out individual cells during blood tests, highlighting those affected by leukemia.”
Washington Post reporter Laurie McGinley writes that Prof. Tyler Jacks, director of the Koch Institute for Integrative Cancer Research, was named to a panel of experts that will advise the Obama administration on the cancer “moonshot” initiative and how to best “tackle some of the most promising but challenging areas in research today.”